Enhancing Hope Among Patients With Poor-Prognosis Breast Cancer and Oncologists
Status unconfirmed · Not applicable
Conditions studied: Despair Among Cancer Patients and Oncologists
In brief
The study will access whether breast cancer patients and oncologists can become more hopeful after participating in a "hope enhancement workshop." Several validated tools, Adult Hope Scale (AHS), Herth Hope Index (HHI), Maslach Burnout Inventory (MBI)" and other quality of life parameter surveys, will be administered at specified intervals.
Key facts
- Study ID
- NCT03074071
- Run by
- Tel-Aviv Sourasky Medical Center
- People needed
- 120
- Starts
- 2017-11-08
- Expected to finish
- 2020-12-01
- Last updated by the study team
- 2017-11-27
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Inclusion Criteria (patient component of study)
- Diagnosis of invasive breast cancer that is Stage IV.
- Female, 18 years of age or older.
- Able to proficiently speak, read, write English.
- ECOG performance status between 0 and 3.
- Subjects must have a smartphone with at least "3rd generation" mobile technology, and willingness to download and utilize specialized application
- Expected to continue cancer care at the institution where cancer was begun for the duration of the study.
- Inclusion Criteria (physician component of study)
- Board certification or board eligibility in any of the 3 oncologic disciplines:
- Medical Oncology
- Surgical Oncology
- Radiation Oncology
- Able to proficiently speak, read, write English.
- Subjects must have a smartphone with at least "3rd generation" mobile technology, and willingness to download and utilize specialized application
- NB: There will not be active recruitment of physicians who are subordinate to the respective investigators. In the event that such a physician desires to enroll on the study, formal application will be made to the institutional ethics committees to verify that coercion has not taken place.
You may not qualify if…
- Exclusion Criteria (applies to both patients and physicians)
- Participant actively undergoing psychotherapy for depression.
- Documented history of Alzheimer's disease or other forms of dementia.
- Participants practicing mindfulness meditation for an average of more than 1 hour/week.
Where it is running
- Johns Hopkins University School of Medicine — Baltimore, Maryland, United States
- Tel Aviv Sourasky Medical Center — Tel Aviv, Israel
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.